# Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for

> **NCT06172387** · PHASE1 · UNKNOWN · sponsor: **Tianjin Huanhu Hospital** · enrollment: 46 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** intra-arterial infusion albumin
- **OTHER:** mechanical thrombectomy and a standard clinical therapy

## Key facts

- **NCT ID:** NCT06172387
- **Lead sponsor:** Tianjin Huanhu Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06172387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06172387, "Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06172387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*